- The 10 authors are physicians, researchers and academics specializing in HIV treatment and research.
As infectious disease professionals living and working as HIV doctors and researchers in Tennessee, we, in order to correct the record of many falsehoods in the April 25th Guest Opinion section: It is written as
The efficacy of HIV antiretroviral therapy is evident. As a result of increased use in the United States, HIV-related deaths here have halved since 2010.
In addition, it has been found that when people living with HIV receive this treatment, their viral levels become undetectable and they are unable to transmit HIV to others.
This phrase captures the principle of treatment as prevention, in which HIV antiretroviral therapy benefits both people living with HIV (improved quality and length of life) and the wider community by reducing HIV infection. to provide highly cost-effective health benefits.
CDC’s mission and investment have been essential to applying this knowledge and achieving many of the successes that have been achieved in curbing the HIV epidemic so far. Working with local, state, federal, and community partners, CDC guidance and policies are based on the latest and highest quality evidence, including cost considerations. Their guidance is irrelevant to the interests of pharmaceutical companies.
more:Nashville CARES partners with local eateries to raise money and fulfill its mission for HIV aid
Hear more from Tennessee:Get our weekly opinion newsletter for insightful and thought-provoking columns.
Despite significant progress, the HIV epidemic is not over. More than 1 million US adults and adolescents are living with HIV, and in 2020 he had 30,692 new diagnoses. Nearly 20,000 people are living with HIV in Tennessee, with 651 new diagnoses in 2020. Amazingly, only 65% of those diagnosed with HIV in Tennessee have undetectable levels of the virus. Definitely more work is needed.
Poorly informed opinion cannot end the HIV epidemic. Evidence-based HIV treatment is provided. Perpetuating dangerous misinformation only sets us back.
Sign up for the Latino Tennessee Voices newsletter.Read compelling stories for and with the Latino community in Tennessee.
Sign up for the Black Tennessee Voices newsletter:Read compelling columns by Black authors across Tennessee.
April Pettit, MD, MPH (Associate Professor of Medicine, Division of Infectious Diseases and Epidemiology, Vanderbilt University Medical Center; member of the HIV Medical Society)
Anna Parson, M.D., Associate Professor of Infectious Diseases, Vanderbilt University Medical Center; Director, HIV Medical Association
Aima Ahonkhai, MD, MPH (Assistant Professor, Division of Infectious Diseases, Vanderbilt University Medical Center; Member of the HIV Medical Society)
more:CDC funding helps newly diagnosed HIV-positive Tennessees live healthier lives.opinion
Peter Rebeiro, PhD, MHS (Assistant Professor of Biostatistics and Medicine, Department of Infectious Diseases and Epidemiology, and Director of Graduate Studies in Epidemiology, Vanderbilt University Medical Center)
Carolyn Audet, PhD, MSCI (Associate Professor of Health Policy and Medicine, Department of Epidemiology, Vanderbilt University Medical Center; Member of the Association for Implementation Research Cooperation)
Dr. Tara McKay (Assistant Professor of Medicine, Health and Sociology, Vanderbilt University; Fellow of the International AIDS Society)
Daniel Escudero, PhD, MPH (Assistant Professor of Epidemiology, Vanderbilt University Medical Center)
Dr. Christian J. Chandler, M.P.H., Assistant Professor, Infectious Diseases Division, Vanderbilt University Medical Center
L. Lauren Brown, PhD, LCSW (Assistant Professor of Medicine, Department of Infectious Diseases, Vanderbilt University Medical Center)
David Haas, MD (Professor of Medicine, Pharmacology, Pathology, Microbiology and Immunology, Vanderbilt University Medical Center)